INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 88 filers reported holding INSMED INC in Q3 2013. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $27,683 | -44.5% | 1,312 | -47.5% | 0.00% | – |
Q4 2022 | $49,910 | +4891.0% | 2,498 | +6838.9% | 0.00% | – |
Q3 2020 | $1,000 | -99.2% | 36 | -99.6% | 0.00% | -100.0% |
Q1 2020 | $129,000 | -27.9% | 8,055 | +7.5% | 0.00% | 0.0% |
Q4 2019 | $179,000 | +17800.0% | 7,492 | +8224.4% | 0.00% | – |
Q4 2016 | $1,000 | -99.9% | 90 | -99.9% | 0.00% | -100.0% |
Q4 2015 | $1,874,000 | +17.7% | 103,235 | +20.4% | 0.02% | 0.0% |
Q3 2015 | $1,592,000 | +81.7% | 85,713 | +138.9% | 0.02% | +83.3% |
Q2 2015 | $876,000 | +202.1% | 35,884 | +157.3% | 0.01% | +140.0% |
Q1 2015 | $290,000 | +41.5% | 13,948 | +5.2% | 0.01% | +66.7% |
Q4 2014 | $205,000 | +101.0% | 13,259 | +69.7% | 0.00% | +50.0% |
Q3 2014 | $102,000 | -95.5% | 7,811 | -93.1% | 0.00% | -94.3% |
Q2 2014 | $2,278,000 | +175.1% | 114,006 | +162.1% | 0.04% | +150.0% |
Q1 2014 | $828,000 | -11.7% | 43,489 | -21.1% | 0.01% | 0.0% |
Q4 2013 | $938,000 | +1776.0% | 55,138 | +1635.5% | 0.01% | +1300.0% |
Q3 2013 | $50,000 | -91.2% | 3,177 | -93.3% | 0.00% | -92.9% |
Q2 2013 | $570,000 | – | 47,698 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |